Working capital / assets moved 401 bp lower
Working capital / assets changed -401 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
76.89%→72.88%4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →IMCR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue moved 213 bp lower
SBC / revenue changed -213 basis points from the comparable as-filed period.
10.24%→8.11%2 prior comparisons
Shares outstanding increased 2.2%
Shares outstanding changed +2.2% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
50,387,068→51,498,6177 prior comparisons
Capital expenditure increased 89.9%
Capital expenditure changed +89.9% from the comparable as-filed period.
$414,000→$786,0003 prior comparisons
Free-cash-flow margin moved 1302 bp lower
Free-cash-flow margin changed -1302 basis points from the comparable as-filed period.
26.08%→13.06%2 prior comparisons
Operating cash-flow margin moved 1276 bp lower
Operating cash-flow margin changed -1276 basis points from the comparable as-filed period.
26.50%→13.74%2 prior comparisons
R&D / revenue moved 666 bp lower
R&D / revenue changed -666 basis points from the comparable as-filed period.
70.44%→63.79%2 prior comparisons
Gross margin moved 12 bp higher
Gross margin changed +12 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
98.94%→99.06%2 prior comparisons
Inventory / revenue moved 115 bp higher
Inventory / revenue changed +115 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
5.57%→6.72%2 prior comparisons
Research & development increased 7.2%
Research & development changed +7.2% from the comparable as-filed period.
$69.0M→$73.9M2 prior comparisons
Capex / revenue moved 26 bp higher
Capex / revenue changed +26 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.42%→0.68%2 prior comparisons
Current assets increased 4.9%
Current assets changed +4.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.0B→$1.1B4 prior comparisons
Total assets increased 3.4%
Total assets changed +3.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.1B→$1.1B4 prior comparisons
Working capital decreased 2.0%
Working capital changed -2.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$832.2M→$815.8M4 prior comparisons
Cash & equivalents decreased 0.6%
Cash & equivalents changed -0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$487.9M→$484.9M4 prior comparisons
Cost of revenue increased 4.6%
Cost of revenue changed +4.6% from the comparable as-filed period.
$1.0M→$1.1M2 prior comparisons
Selling, general & administrative increased 2.6%
Selling, general & administrative changed +2.6% from the comparable as-filed period.
$42.8M→$43.9M2 prior comparisons
Stock-based compensation decreased 6.3%
Stock-based compensation changed -6.3% from the comparable as-filed period.
$10.0M→$9.4M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.